FDA NDC Directory · JSON-LD · Markdown

TACLONEX

NDC 50222-501 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic namecalcipotriene and betamethasone dipropionate
Labeler / ManufacturerLEO Pharma Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022185
Dosage form / routeSUSPENSION · TOPICAL
Active ingredientsBETAMETHASONE DIPROPIONATE (.5 mg/g)
CALCIPOTRIENE HYDRATE (50 ug/g)
Marketing started20080601
Package count2

External sources

Source: openFDA. Public-domain (CC0).